Measles Vaccine Market By Product, Application and End User - Global Industry Analysis And Forecast To 2027
Published On : June 2022 Pages : 140 Category: Pharmaceuticals Report Code : HC063932
Measles Vaccine Market By Product (Mumps Measles Rubella And Varicella Virus Vaccine (Proquad), Live (MMR-II) and Mumps Measles Rubella Vaccine), Application (Adult Vaccines and Pediatric Vaccines) and End User (Vaccination Centers, Clinics and Hospitals) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The Measles diseases is the infection of childhood brought about by virus. When very normal, measles may now quite often be anticipated with vaccination. Additionally known as the rubeola, measles may be fatal and even lethal for the little youngsters. While the rate of death have been falling across the globe as more kids get the measles antibody. Therefore, the Measles Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global Measles Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers & Restrains
The factors responsible for growth of the market are; increasing awareness in the people across the globe, increasing investment by the governments across the globe, more development in technology for production of vaccines and some other factors. The factors limiting the market growth can be alternate treatment methods,
Regional Insights
The North American region is leading the global Measles Vaccine Market owing to factor like; increasing awareness in the region regarding the disease, rise in the vaccination programs and few other factors.
Measles Vaccine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Bavarian Nordic
- GlaxoSmithKline plc
- MedImmune
- Emergent BioSolutions Inc.
- Johnson & Johnson Private Limited
- Merck & Co. Inc.
- CSL Limited
- Sanofi
- Astellas Pharma India Private Limited
- Serum Institute of India Pvt. Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Measles Vaccine Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Mumps Measles Rubella And Varicella Virus Vaccine (Proquad)
o Live (MMR-II)
o Mumps Measles Rubella Vaccine
o Measles Vaccine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Adult Vaccines
o Pediatric Vaccines
o Measles Vaccine Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Vaccination Centers
o Clinics
o Hospitals
o Measles Vaccine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Bavarian Nordic
o GlaxoSmithKline plc
o MedImmune
o Emergent BioSolutions Inc.
o Johnson & Johnson Private Limited
o Merck & Co. Inc.
o CSL Limited
o Sanofi
o Astellas Pharma India Private Limited
o Serum Institute of India Pvt. Ltd.
o Measles Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Measles Vaccine Market, By Country
o U.S. Measles Vaccine Market
o Canada Measles Vaccine Market
o Mexico Measles Vaccine Market
o Europe
§ Europe Measles Vaccine Market, By Country
o Germany Measles Vaccine Market
o UK Measles Vaccine Market
o France Measles Vaccine Market
o Russia Measles Vaccine Market
o Italy Measles Vaccine Market
o Rest of Europe Measles Vaccine Market
o Asia-Pacific
§ Asia-Pacific Measles Vaccine Market, By Country
o China Measles Vaccine Market
o Japan Measles Vaccine Market
o South Korea Measles Vaccine Market
o India Measles Vaccine Market
o Southeast Asia Measles Vaccine Market
o Rest of Asia-Pacific Measles Vaccine Market
o South America
§ South America Measles Vaccine Market, By Country
o Brazil Measles Vaccine Market
o Argentina Measles Vaccine Market
o Columbia Measles Vaccine Market
o Rest of South America Measles Vaccine Market
o Middle East and Africa
§ Middle East and Africa Measles Vaccine Market, By Country
o Saudi Arabia Measles Vaccine Market
o UAE Measles Vaccine Market
o Egypt Measles Vaccine Market
o Nigeria Measles Vaccine Market
o South Africa Measles Vaccine Market
o Rest of MEA Measles Vaccine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Measles Vaccine Market, By Product
5.1. Introduction
5.2. Global Measles Vaccine Revenue and Market Share by Product (2017-2027)
5.2.1. Global Measles Vaccine Revenue and Revenue Share by Product (2017-2027)
5.3. Mumps Measles Rubella And Varicella Virus Vaccine (Proquad)
5.3.1. Global Mumps Measles Rubella And Varicella Virus Vaccine (Proquad) Revenue and Growth Rate (2017-2027)
5.4. Live (MMR-II)
5.4.1. Global Live (MMR-II) Revenue and Growth Rate (2017-2027)
5.5. Mumps Measles Rubella Vaccine
5.5.1. Global Mumps Measles Rubella Vaccine Revenue and Growth Rate (2017-2027)
6. Measles Vaccine Market, By Application
6.1. Introduction
6.2. Global Measles Vaccine Revenue and Market Share by Application (2017-2027)
6.2.1. Global Measles Vaccine Revenue and Revenue Share by Application (2017-2027)
6.3. Adult Vaccines
6.3.1. Global Adult Vaccines Revenue and Growth Rate (2017-2027)
6.4. Pediatric Vaccines
6.4.1. Global Pediatric Vaccines Revenue and Growth Rate (2017-2027)
7. Measles Vaccine Market, By End User
7.1. Introduction
7.2. Global Measles Vaccine Revenue and Market Share by End User (2017-2027)
7.2.1. Global Measles Vaccine Revenue and Revenue Share by End User (2017-2027)
7.3. Vaccination Centers
7.3.1. Global Vaccination Centers Revenue and Growth Rate (2017-2027)
7.4. Clinics
7.4.1. Global Clinics Revenue and Growth Rate (2017-2027)
7.5. Hospitals
7.5.1. Global Hospitals Revenue and Growth Rate (2017-2027)
8. Measles Vaccine Market, By Region
8.1. Introduction
8.2. Global Measles Vaccine Revenue and Market Share by Regions
8.2.1. Global Measles Vaccine Revenue by Regions (2017-2027)
8.3. North America Measles Vaccine by Countries
8.3.1. North America Measles Vaccine Revenue and Growth Rate (2017-2027)
8.3.2. North America Measles Vaccine Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Measles Vaccine by Countries
8.4.1. Europe Measles Vaccine Revenue and Growth Rate (2017-2027)
8.4.2. Europe Measles Vaccine Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Measles Vaccine by Countries
8.5.1. Asia-Pacific Measles Vaccine Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Measles Vaccine Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Measles Vaccine by Countries
8.6.1. South America Measles Vaccine Revenue and Growth Rate (2017-2027)
8.6.2. South America Measles Vaccine Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Measles Vaccine by Countries
8.7.1. Middle East and Africa Measles Vaccine Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Measles Vaccine Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Bavarian Nordic
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. GlaxoSmithKline plc
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. MedImmune
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Emergent BioSolutions Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Johnson & Johnson Private Limited
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Merck & Co. Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. CSL Limited
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Sanofi
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Astellas Pharma India Private Limited
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Serum Institute of India Pvt. Ltd.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Measles Vaccine Market Forecast (2017-2027)
10.1. Global Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Measles Vaccine Market Forecast by Regions (2017-2027)
10.2.1. North America Measles Vaccine Market Forecast (2017-2027)
10.2.1.1. United States Measles Vaccine Market Forecast (2017-2027)
10.2.1.2. Canada Measles Vaccine Market Forecast (2017-2027)
10.2.1.3. Mexico Measles Vaccine Market Forecast (2017-2027)
10.2.2. Europe Measles Vaccine Market Forecast (2017-2027)
10.2.2.1. Germany Measles Vaccine Market Forecast (2017-2027)
10.2.2.2. France Measles Vaccine Market Forecast (2017-2027)
10.2.2.3. UK Measles Vaccine Market Forecast (2017-2027)
10.2.2.4. Russia Measles Vaccine Market Forecast (2017-2027)
10.2.2.5. Italy Measles Vaccine Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Measles Vaccine Market Forecast (2017-2027)
10.2.3. Asia-Pacific Measles Vaccine Market Forecast (2017-2027)
10.2.3.1. China Measles Vaccine Market Forecast (2017-2027)
10.2.3.2. Japan Measles Vaccine Market Forecast (2017-2027)
10.2.3.3. Korea Measles Vaccine Market Forecast (2017-2027)
10.2.3.4. India Measles Vaccine Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Measles Vaccine Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Measles Vaccine Market Forecast (2017-2027)
10.2.4. South America Measles Vaccine Market Forecast (2017-2027)
10.2.4.1. Brazil Measles Vaccine Market Forecast (2017-2027)
10.2.4.2. Argentina Measles Vaccine Market Forecast (2017-2027)
10.2.4.3. Columbia Measles Vaccine Market Forecast (2017-2027)
10.2.4.4. Rest of South America Measles Vaccine Market Forecast (2017-2027)
10.2.5. Middle East and Africa Measles Vaccine Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Measles Vaccine Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Measles Vaccine Market Forecast (2017-2027)
10.2.5.3. Egypt Measles Vaccine Market Forecast (2017-2027)
10.2.5.4. Nigeria Measles Vaccine Market Forecast (2017-2027)
10.2.5.5. South Africa Measles Vaccine Market Forecast (2017-2027)
10.2.5.6. Turkey Measles Vaccine Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Measles Vaccine Market Forecast (2017-2027)
10.3. Measles Vaccine Market Forecast by Product (2017-2027)
10.3.1. Measles Vaccine Forecast by Product (2017-2027)
10.3.2. Measles Vaccine Market Share Forecast by Product (2017-2027)
10.4. Measles Vaccine Market Forecast by Application (2017-2027)
10.4.1. Measles Vaccine Forecast by Application (2017-2027)
10.4.2. Measles Vaccine Market Share Forecast by Application (2017-2027)
10.5. Measles Vaccine Market Forecast by End User (2017-2027)
10.5.1. Measles Vaccine Forecast by End User (2017-2027)
10.5.2. Measles Vaccine Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Measles Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Measles Vaccine Revenue and Revenue Share by Product (2017-2018)
Figure Global Mumps Measles Rubella And Varicella Virus Vaccine (Proquad) Revenue and Growth Rate (2017-2018)
Figure Global Live (MMR-II) Revenue and Growth Rate (2017-2018)
Figure Global Mumps Measles Rubella Vaccine Revenue and Growth Rate (2017-2018)
Table Global Measles Vaccine Revenue and Revenue Share by Application (2017-2018)
Figure Global Adult Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Pediatric Vaccines Revenue and Growth Rate (2017-2018)
Table Global Measles Vaccine Revenue and Revenue Share by End User (2017-2018)
Figure Global Vaccination Centers Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Measles Vaccine Revenue by Regions (2017-2018)
Figure North America Measles Vaccine Growth Rate (2017-2018)
Figure North America Measles Vaccine Revenue and Growth Rate (2017-2018)
Figure North America Measles Vaccine by Countries (2017-2018)
Figure North America Measles Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure United States Measles Vaccine Growth Rate (2017-2018)
Figure United States Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Measles Vaccine Growth Rate (2017-2018)
Figure Canada Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Measles Vaccine Growth Rate (2017-2018)
Figure Mexico Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Measles Vaccine Growth Rate (2017-2018)
Figure Europe Measles Vaccine Revenue and Growth Rate (2017-2018)
Figure Europe Measles Vaccine by Countries (2017-2018)
Figure Europe Measles Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Measles Vaccine Growth Rate (2017-2018)
Figure Germany Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Measles Vaccine Growth Rate (2017-2018)
Figure France Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Measles Vaccine Growth Rate (2017-2018)
Figure UK Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Measles Vaccine Growth Rate (2017-2018)
Figure Russia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Measles Vaccine Growth Rate (2017-2018)
Figure Italy Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Measles Vaccine Growth Rate (2017-2018)
Figure Rest of Europe Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Measles Vaccine Growth Rate (2017-2018)
Figure Asia-Pacific Measles Vaccine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Measles Vaccine by Countries (2017-2018)
Figure Asia-Pacific Measles Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure China Measles Vaccine Growth Rate (2017-2018)
Figure China Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Measles Vaccine Growth Rate (2017-2018)
Figure Japan Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Measles Vaccine Growth Rate (2017-2018)
Figure Korea Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Measles Vaccine Growth Rate (2017-2018)
Figure India Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Measles Vaccine Growth Rate (2017-2018)
Figure Southeast Asia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Measles Vaccine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Measles Vaccine Growth Rate (2017-2018)
Figure South America Measles Vaccine Revenue and Growth Rate (2017-2018)
Figure South America Measles Vaccine by Countries (2017-2018)
Figure South America Measles Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Measles Vaccine Growth Rate (2017-2018)
Figure Brazil Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Measles Vaccine Growth Rate (2017-2018)
Figure Argentina Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Measles Vaccine Growth Rate (2017-2018)
Figure Columbia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Measles Vaccine Growth Rate (2017-2018)
Figure Rest of South America Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Measles Vaccine Growth Rate (2017-2018)
Figure Middle East and Africa Measles Vaccine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Measles Vaccine by Countries (2017-2018)
Figure Middle East and Africa Measles Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Measles Vaccine Growth Rate (2017-2018)
Figure Saudi Arabia Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Measles Vaccine Growth Rate (2017-2018)
Figure United Arab Emirates Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Measles Vaccine Growth Rate (2017-2018)
Figure Egypt Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Measles Vaccine Growth Rate (2017-2018)
Figure Nigeria Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Measles Vaccine Growth Rate (2017-2018)
Figure South Africa Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Measles Vaccine Growth Rate (2017-2018)
Figure Turkey Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Measles Vaccine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Measles Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bavarian Nordic Measles Vaccine Financial Overview
Table GlaxoSmithKline plc Measles Vaccine Financial Overview
Table MedImmune Measles Vaccine Financial Overview
Table Emergent BioSolutions Inc. Measles Vaccine Financial Overview
Table Johnson & Johnson Private Limited Measles Vaccine Financial Overview
Table Merck & Co. Inc. Measles Vaccine Financial Overview
Table CSL Limited Measles Vaccine Financial Overview
Table Sanofi Measles Vaccine Financial Overview
Table Astellas Pharma India Private Limited Measles Vaccine Financial Overview
Table Serum Institute of India Pvt. Ltd. Measles Vaccine Financial Overview
Figure Global Measles Vaccine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Measles Vaccine Market Forecast by Regions (2018-2025)
Figure North America Measles Vaccine Market Forecast (2018-2025)
Figure United States Measles Vaccine Market Forecast (2018-2025)
Figure Canada Measles Vaccine Market Forecast (2018-2025)
Figure Mexico Measles Vaccine Market Forecast (2018-2025)
Figure Europe Measles Vaccine Market Forecast (2018-2025)
Figure Germany Measles Vaccine Market Forecast (2018-2025)
Figure France Measles Vaccine Market Forecast (2018-2025)
Figure UK Measles Vaccine Market Forecast (2018-2025)
Figure Russia Measles Vaccine Market Forecast (2018-2025)
Figure Italy Measles Vaccine Market Forecast (2018-2025)
Figure Rest of Europe Measles Vaccine Market Forecast (2018-2025)
Figure Asia-Pacific Measles Vaccine Market Forecast (2018-2025)
Figure China Measles Vaccine Market Forecast (2018-2025)
Figure Japan Measles Vaccine Market Forecast (2018-2025)
Figure Korea Measles Vaccine Market Forecast (2018-2025)
Figure India Measles Vaccine Market Forecast (2018-2025)
Figure Southeast Asia Measles Vaccine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Measles Vaccine Market Forecast (2018-2025)
Figure South America Measles Vaccine Market Forecast (2018-2025)
Figure Brazil Measles Vaccine Market Forecast (2018-2025)
Figure Argentina Measles Vaccine Market Forecast (2018-2025)
Figure Columbia Measles Vaccine Market Forecast (2018-2025)
Figure Rest of South America Measles Vaccine Market Forecast (2018-2025)
Figure Middle East and Africa Measles Vaccine Market Forecast (2018-2025)
Figure Saudi Arabia Measles Vaccine Market Forecast (2018-2025)
Figure United Arab Emirates Measles Vaccine Market Forecast (2018-2025)
Figure Egypt Measles Vaccine Market Forecast (2018-2025)
Figure Nigeria Measles Vaccine Market Forecast (2018-2025)
Figure South Africa Measles Vaccine Market Forecast (2018-2025)
Figure Turkey Measles Vaccine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Measles Vaccine Market Forecast (2018-2025)
Figure Global Measles Vaccine Forecast by Product (2018-2025)
Figure Global Measles Vaccine Market Share Forecast by Product (2018-2025)
Figure Global Measles Vaccine Forecast by Product (2018-2025)
Figure Global Measles Vaccine Forecast by Application (2018-2025)
Figure Global Measles Vaccine Market Share Forecast by Application (2018-2025)
Figure Global Measles Vaccine Forecast by Application (2018-2025)
Figure Global Measles Vaccine Forecast by End User (2018-2025)
Figure Global Measles Vaccine Market Share Forecast by End User (2018-2025)
Figure Global Measles Vaccine Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|